ResearcherEmory UniversityActive in the last 2 years
Maria Citarella Russell
Matched on ORCID iD 0000-0003-1584-6992; OpenAlex author ID A5036799246. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 4 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 7
- Prehabilitation and Immunonutrition in Pancreatic Cancer Therapy. Last author DOI 10.1016/j.soc.2025.03.004↗
- Adjuvant Therapy for Pancreatic Adenocarcinoma-Leaving No Rock Unturned. First author DOI 10.1001/jamaoncol.2022.5786↗
- Optimal timing and treatment strategy for pancreatic cancer. Co-author DOI 10.1002/jso.25976↗
- The Path to Whipple Reconstruction for Pancreatic Adenocarcinoma: Trans-Mesocolon or Through Ligament of Treitz? Co-author DOI 10.1007/s11605-019-04377-9↗
- Association of ABO blood group with survival following pancreatoduodenectomy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hpb.2020.01.004↗
- In-hospital 30-day mortality for older patients with pancreatic cancer undergoing pancreaticoduodenectomy. Co-author DOI 10.1016/j.jgo.2019.10.012↗
- Is prior cholecystectomy associated with decreased survival in patients with resectable pancreatic adenocarcinoma following pancreaticoduodenectomy? Co-author DOI 10.1016/j.amjsurg.2010.02.004↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Madeline D. Roorbach · 1 shared paper, 2026 · strength 0.50
- Shishir Kumar Maithel · 4 shared papers, 2020 · strength 0.43
- Paper The Path to Whipple Reconstruction for Pancreatic Adenocarcinoma: Trans-Mesocolon or Through Ligament of Treitz? DOI 10.1007/s11605-019-04377-9↗
- Paper Association of ABO blood group with survival following pancreatoduodenectomy for pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2020.01.004↗
- Paper Optimal timing and treatment strategy for pancreatic cancer. DOI 10.1002/jso.25976↗
- David A. Kooby · 4 shared papers, 2011–2020 · strength 0.36
- Paper The Path to Whipple Reconstruction for Pancreatic Adenocarcinoma: Trans-Mesocolon or Through Ligament of Treitz? DOI 10.1007/s11605-019-04377-9↗
- Paper Association of ABO blood group with survival following pancreatoduodenectomy for pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2020.01.004↗
- Paper Optimal timing and treatment strategy for pancreatic cancer. DOI 10.1002/jso.25976↗
- Juan Manuel Sarmiento · 3 shared papers, 2020 · strength 0.33
- Paper The Path to Whipple Reconstruction for Pancreatic Adenocarcinoma: Trans-Mesocolon or Through Ligament of Treitz? DOI 10.1007/s11605-019-04377-9↗
- Paper Association of ABO blood group with survival following pancreatoduodenectomy for pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2020.01.004↗
- Paper In-hospital 30-day mortality for older patients with pancreatic cancer undergoing pancreaticoduodenectomy. DOI 10.1016/j.jgo.2019.10.012↗
- Meredith C. Mason · 1 shared paper, 2023 · strength 0.31
- Nader Nabile Massarweh · 1 shared paper, 2023 · strength 0.31
- Adriana Carolina Gamboa · 2 shared papers, 2020 · strength 0.22
- Hannah Williams · 1 shared paper, 2020 · strength 0.11
- Mihir M. Shah · 1 shared paper, 2020 · strength 0.11
- Astrid Belalcazar · 1 shared paper, 2020 · strength 0.10
- Christina Sing-Ying Wu · 1 shared paper, 2020 · strength 0.10
- Olatunji Boladale Alese · 1 shared paper, 2020 · strength 0.10
- Walid Labib Shaib · 1 shared paper, 2020 · strength 0.10
- Mehmet Akce · 1 shared paper, 2020 · strength 0.10
- Bassel F. El‐Rayes · 1 shared paper, 2020 · strength 0.10
- Suzanne Schiffman · 1 shared paper, 2011 · strength 0.03
- Charles Raben Scoggins · 1 shared paper, 2011 · strength 0.03
- Robert C.G. Martin · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.